These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 8309684)

  • 1. [Acute parotitis in children previously vaccinated against mumps].
    Mihály I; Budai J; Gerö A; Kukán E
    Orv Hetil; 1994 Feb; 135(6):287-90. PubMed ID: 8309684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology of epidemic parotitis].
    Mihály I; Kukán E; Gellért M; Gerö A; Mándoky F
    Orv Hetil; 1994 Jan; 135(1):3-6. PubMed ID: 8290235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella.
    Davidkin I; Jokinen S; Paananen A; Leinikki P; Peltola H
    J Infect Dis; 2005 Mar; 191(5):719-23. PubMed ID: 15688285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects and complications of measles-mumps vaccination].
    von Mühlendahl KE
    Monatsschr Kinderheilkd; 1989 Aug; 137(8):440-6. PubMed ID: 2682212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnosis of the viral etiology of suspected mumps in a population with high vaccine coverage].
    Limberková R; Havlíčková M; Smíšková D; Labská K; Herrmannová K; Procházková J; Jiřincová H; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(4):220-224. PubMed ID: 28078898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.
    Barrabeig I; Costa J; Rovira A; Marcos MA; Isanta R; López-Adalid R; Cervilla A; Torner N; Domínguez A
    Hum Vaccin Immunother; 2015; 11(1):282-7. PubMed ID: 25483547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological diagnosis of parainfluenza virus infections: verification of the sensitivity and specificity of the haemagglutination-inhibition (HI), complement-fixation (CF), immunofluorescence (IFA) tests and enzyme immunoassay (ELISA).
    Fedová D; Novotný J; Kubínová I
    Acta Virol; 1992 May; 36(3):304-12. PubMed ID: 1360758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine induced mumps-like diseases.
    Quast U; Hennessen W; Widmark RM
    Dev Biol Stand; 1979; 43():269-72. PubMed ID: 520674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
    Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
    Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral etiology of sporadic cases of parotitis among children in Korea during 2013-2014.
    Kang HJ; Kim SH; Chung JK; Lee SW; Choi SB; Eom HE; Park O; Kim K; Kim SS
    J Med Virol; 2018 Jan; 90(1):61-66. PubMed ID: 28876460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.
    Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of indigenously produced MMR vaccine.
    Bhargava I; Chhaparwal BC; Phadke MA; Irani SF; Chhaparwal D; Dhorje S; Maheshwari CP
    Indian Pediatr; 1995 Sep; 32(9):983-8. PubMed ID: 8935261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral etiology of parotitis.
    Meurman O; Vainionpää R; Rossi T; Hänninen P
    Scand J Infect Dis; 1983; 15(2):145-8. PubMed ID: 6308753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.